Christopher Droogan

Summary

Affiliation: Lankenau Institute for Medical Research
Country: USA

Publications

  1. pmc Left ventricular assist device implantation in high risk destination therapy patients: an alternative surgical approach
    Louis E Samuels
    Department of Surgery, Division of Cardiothoracic Surgery, Lankenau Medical Center, Wynnewood, PA, USA
    J Cardiothorac Surg 7:21. 2012
  2. pmc Cardiogenic shock associated with loco-regional anesthesia rescued with left ventricular assist device implantation
    Louis E Samuels
    Department of Cardiothoracic Surgery, Lankenau Hospital, Wynnewood, PA, USA
    J Cardiothorac Surg 5:126. 2010
  3. doi request reprint Role of antiarrhythmic drugs: frequent implantable cardioverter-defibrillator shocks, risk of proarrhythmia, and new drug therapy
    Christopher Droogan
    Department of Cardiology, Main Line Health Heart Center and Lankenau Hospital, 100 Lancaster Avenue, MOBE 356, Wynnewood, PA 19096, USA
    Heart Fail Clin 7:195-205, viii. 2011

Collaborators

  • Peter R Kowey
  • Louis E Samuels
  • Elena Casanova-Ghosh
  • Roberto Rodriguez

Detail Information

Publications3

  1. pmc Left ventricular assist device implantation in high risk destination therapy patients: an alternative surgical approach
    Louis E Samuels
    Department of Surgery, Division of Cardiothoracic Surgery, Lankenau Medical Center, Wynnewood, PA, USA
    J Cardiothorac Surg 7:21. 2012
    ..The purpose of this report is to describe an alternative implantation approach for the implantation of the Heartmate II™ LVAD in high risk DT patients...
  2. pmc Cardiogenic shock associated with loco-regional anesthesia rescued with left ventricular assist device implantation
    Louis E Samuels
    Department of Cardiothoracic Surgery, Lankenau Hospital, Wynnewood, PA, USA
    J Cardiothorac Surg 5:126. 2010
    ..Twenty-four hours later, cardiac function normalized and the LVAD was removed. The patient was discharged five days later and remained with normal heart function in three-year follow-up...
  3. doi request reprint Role of antiarrhythmic drugs: frequent implantable cardioverter-defibrillator shocks, risk of proarrhythmia, and new drug therapy
    Christopher Droogan
    Department of Cardiology, Main Line Health Heart Center and Lankenau Hospital, 100 Lancaster Avenue, MOBE 356, Wynnewood, PA 19096, USA
    Heart Fail Clin 7:195-205, viii. 2011
    ..This article describes data supporting the need for and potential risks and benefits of adjuvant antiarrhythmic drug therapy and examines the benefits and pitfalls of the same in ICD-implanted patients...